Home > Publications > Medical Specialty > Dermatology > Chronic Spontaneous Urticaria > Chronic Spontaneous Urticaria Research Review Issue 2
Chronic Spontaneous Urticaria Research Review Issue 2

Chronic Spontaneous Urticaria Research Review Issue 2

In this issue:

REMIX-1 & -2 trials: remibrutinib in CSU
Paradoxical urticaria with H1 antihistamines
Urticaria Voices survey: disease burden of CSU
Chronic urticaria after COVID-19 infection
CSU prognosis after omalizumab nonresponse
Real-world omalizumab for CIndU
Gut dysbiosis in refractory CSU
Teledermatology for CSU
WAO position on CSU remission
Ligelizumab in refractory CSU

You need to be logged in to access this content.

Annika-Smith

Expert contributor

Associate Professor Annika Smith

Dr Annika Smith is a Fellow of the Australasian College of Dermatologists and Consultant Dermatologist in public and private settings in Sydney. Annika undertook training at the prestigious St John’s Institute of Dermatology London, followed by further sub-specialty training in New York. Annika has a special interest in complex medical dermatology, including clinical and research […]

Latest Publications and Videos

Stay up to date with our latest clinical information.

Explore Research Review Publications and Videos

Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry. 

Find Reviews in Your Clinical Area
Please select your country of practice.

It looks like you are closest to our New Zealand site.

Terms and Conditions

Website terms of use 

By using our website, you agree to follow these terms and conditions. 

 

Privacy policy 

We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms. 

 

Copyright and use of website content 

The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use. 

You cannot:  copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission. 

 

Links to third-party websites 

The Research Review website may link to third-party websites for your convenience. However: 

We do not endorse or approve their products, services, or actions. 

We are not responsible for their content or how they operate. 

There is no formal partnership between us and third parties unless we clearly state otherwise. 

 

Disclaimer and limitation of liability 

We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date. 

To the fullest extent allowed by law, we are not responsible for: 

Any loss, damage, or costs you may suffer from using (or being unable to use) our website. 

Any decisions you make based on the information provided. 

Any business losses, such as lost profits, lost data, or business interruptions. 

 

Governing law 

These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.